Seres Therapeutics, Inc.
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, …
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Seres Therapeutics, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| NanoString Technologies, Inc. | FMP | High | United States | Seattle | |
| Fate Therapeutics, Inc. | FMP | High | United States | San Diego | |
| Syros Pharmaceuticals, Inc. | FMP | High | United States | Cambridge | |
| Veracyte, Inc. | FMP | High | United States | South San Francisco | |
| Iovance Biotherapeutics, Inc. | FMP | High | United States | San Carlos |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |